Compare ASPN & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASPN | FDMT |
|---|---|---|
| Founded | 2001 | 2013 |
| Country | United States | United States |
| Employees | 854 | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 447.5M | 479.9M |
| IPO Year | 2011 | 2019 |
| Metric | ASPN | FDMT |
|---|---|---|
| Price | $5.36 | $8.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | $4.25 | ★ $31.71 |
| AVG Volume (30 Days) | ★ 2.0M | 567.3K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 18.79 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $271,103,000.00 | $85,209,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $50.03 | $70.28 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 230194.60 |
| 52 Week Low | $2.30 | $3.37 |
| 52 Week High | $9.78 | $12.34 |
| Indicator | ASPN | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 67.31 | 37.31 |
| Support Level | $3.01 | $6.22 |
| Resistance Level | $7.46 | $8.80 |
| Average True Range (ATR) | 0.43 | 0.67 |
| MACD | 0.13 | -0.11 |
| Stochastic Oscillator | 72.50 | 6.47 |
Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology, supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Thermal Barrier segment and the United States market. Some of its products include Pyrogel XTE, Cryogel Z, Spaceloft Subsea, and others.
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).